Micro-Mesoneedling: Understanding the Four MCCM Options and Their Limits

Direct answer: what is micro-mesoneedling?

Micro-mesoneedling here refers to combining fine-needle skin treatment with a protocol involving targeted skincare formulations. Réhabital’s catalogue includes four MCCM options: Skin Repair, Brightening MelanoOut, Regenerative Plus with PDRN and hyaluronic acid, and Premium Exosome. These names describe the clinic’s offering. They do not guarantee effectiveness or establish authorization for every combination of device and product.

The main distinction from standard microneedling is the emphasis on selecting a formulation. That does not automatically make the procedure better or appropriate for every person. Product compatibility with punctured skin, allergies and the strength of the evidence need discussion before deciding. The micro-mesoneedling service page provides the current offering, while this article focuses on understanding the choices and their limitations.

Microneedling, micro-mesoneedling and injected mesotherapy

Standard microneedling is generally discussed in terms of the skin repair response and remodelling. Micro-mesoneedling adds a discussion about the products used and their intended purpose. Injected mesotherapy involves injecting substances into tissue. These terms are not interchangeable and should not lead someone to book a procedure different from the one that was explained. Ask about the actual technique rather than relying on a treatment name.

The offering described in this article should not be equated with fillers, Botox, platelet-rich plasma or radiofrequency microneedling. Those procedures have different indications, risks and professional requirements. Before booking, ask what will be done, which products will be applied and which areas are proposed. A commercial label is not enough to understand an intervention or to establish that it is suitable for you.

Why a topical product is not automatically compatible

Intact skin acts as a barrier. Microneedling temporarily changes that barrier, which changes the safety questions surrounding a formulation. A familiar ingredient in a serum does not prove that the entire product is suitable for this route of use. Sterility, other ingredients, concentration and manufacturer instructions matter. A skincare product designed for ordinary surface application should not be assumed suitable merely because its name sounds clinical.

The FDA explains that its microneedling device authorizations do not authorize using the devices with cosmetics or other products. That United States guidance does not determine Canadian regulatory status, but it highlights the need to evaluate the combination rather than only the device. This article does not establish Canadian authorization of the combinations described. Ask for a clear explanation instead of a general reassurance based on the word professional.

Skin Repair: understand the name and intended goal

Skin Repair is listed as an option for texture, radiance and early visible ageing concerns. The word repair does not mean that the procedure repairs a skin disease, wound or a person’s DNA damage. It is a product and aesthetic protocol name that should be interpreted with reasonable expectations. No product-specific clinical result at Réhabital is established simply by listing the offering.

The service description mentions several active ingredients. For an individual decision, ask for the exact formulation being used, its precautions and compatibility with your usual skincare. Someone with retinoid irritation or a history of allergies may need a different approach. The right choice is not the option with the most promising name; it is the option whose suitability, limitations and safety have been clearly explained.

Brightening MelanoOut: pigmentation has different causes

MelanoOut is the catalogue option oriented toward uneven tone and the appearance of dark marks. A sun-related spot, pigment after a blemish and melasma are not the same concern. Pigment depth, inflammation and hormonal factors can influence treatment selection. Our hyperpigmentation information page offers context for distinguishing these situations instead of assuming every brown mark needs the same procedure.

Listing this option does not establish that it cures melasma or permanently removes all pigmentation. Inflammation caused by a procedure can sometimes worsen dark marks. Dermatological consultation may be more appropriate for unexplained or persistent pigment changes. A changing mole or a bleeding lesion needs medical assessment rather than treatment as an ordinary cosmetic imperfection. The first decision is identifying the concern, not selecting a brightening label.

Regenerative Plus: PDRN and hyaluronic acid

The Regenerative Plus name includes PDRN and hyaluronic acid. Hyaluronic acid is known for hydration-related properties in certain formulations. PDRN is being studied in different settings. However, findings from an injectable route or a different clinical indication cannot automatically be transferred to the protocol described here. Ingredient-level discussion is not the same as evidence for a finished product used with microneedling.

Do not interpret regenerative as a promise to create new tissue or reverse ageing. Ask about ingredient sources, allergy precautions and the evidence for the exact formulation and its route of use. Disclose a known fish allergy when marine-derived ingredients are relevant. The practitioner should check the actual product rather than assume all formulations containing a similarly named ingredient have identical sources, precautions or effects.

Premium Exosome: separate the offering from promises

Premium Exosome is the name of a fourth catalogue option, presented with an MCCM Exosome PDRN complex. The word exosome appears in many aesthetic discussions, but it does not by itself define a product’s exact composition, source or level of evidence. Those details need checking for the formulation that would actually be used. The commercial name should not be treated as a substitute for that information.

This article makes no claim of stem-cell therapy, proven cellular regeneration or superiority over the other options. A higher price does not establish an additional benefit. Ask which data concern the finished product, what is known about risks and what uncertainties remain. Choosing a simpler option or postponing treatment is reasonable when the available information does not support an informed decision.

How should you choose among the four options?

Start by describing the concern, how long it has been present and what you have already tried. Dehydrated skin, an indented scar and a pigmented mark do not automatically justify the same protocol. The consultation should consider whether a less invasive facial, a simpler routine or dermatological assessment would be more appropriate. A product menu is not a diagnosis or a substitute for suitability screening.

Ask for an observable goal and a reassessment point. For example, the appearance of selected irregularities can be discussed without promising perfect skin. The plan should change if tolerance is poor or benefit remains limited. Moving from one formulation to another solely because the name sounds more advanced is not a sound decision rule. Your circumstances, precautions and the available information should guide the choice.

Safety questions before proceeding

Disclose medications, pregnancy or breastfeeding, allergies, infection, cold sore outbreaks and a tendency toward abnormal scars. Skin with an eczema flare, irritation or sunburn may require postponement. Never change a prescription without the prescriber’s advice to make a procedure possible. Suitability screening needs to account for both general needling risks and the additional questions raised by the selected formulation.

Ask about product handling, traceability and sterile single-use cartridges. Relevant training and a clear scope of practice are important, but they do not remove every risk. Infection, allergic reaction, scarring and persistent colour changes remain possibilities that deserve discussion. Information before treatment should allow you to decline or postpone without commercial pressure. A package discount should not be the deciding factor when safety questions remain unanswered.

After the session: do not improvise an infusion at home

Follow written instructions about cleansing, protection and permitted products. Do not recreate the protocol with a home roller or apply a cocktail bought online to freshly treated skin. Online availability tells you nothing reliable about sterility, authenticity or suitability. A formula that sounds similar may not be the same product, and a professional treatment description is not an instruction for unsupervised use.

Our microneedling preparation and recovery guide explains general precautions. Increasing pain, fever, pus, blisters or spreading redness needs prompt advice. Breathing difficulty or substantial swelling requires urgent help. An unexpected reaction should be assessed rather than covered with new serums or makeup. Contact the clinic and seek medical input when symptoms exceed expected temporary discomfort.

Appointment length, treatment course and realistic expectations

The current catalogue lists a seventy-five-minute appointment for these options. That refers to the complete appointment, not seventy-five minutes of continuous needling. The time devoted to each stage and any adaptations should be explained during consultation. Appointment length is a practical planning detail rather than evidence that one protocol is more effective than another.

The clinic offers individual sessions and packages, but you do not need to select a series before assessment. Session number, spacing and reasons to stop should reflect your skin and response. Results may be limited, variable or insufficient for your goal. A photograph taken immediately afterward may reflect redness or swelling rather than lasting remodelling. It cannot establish that a formulation is superior or that everyone should purchase the same course.

The Réhabital team and practical information

In Côte Saint-Luc on the Island of Montréal, the aesthetic team includes Liliana Ciocoi, Elena Caliniuc and Farzaneh Badakhshan. Confirm availability for the service and practitioner you want. Réhabital is located at D4-5800 Cavendish Boulevard in Cavendish Mall, with ground-floor access and free parking.

The fees catalogue provides current prices for each option, packages and tax information, and remains the reference when comparing total cost. Aesthetic procedures are not covered by private insurance at the clinic. Ask questions by calling 438-842-3550 and book through Jane App. There is no reason to select the highest-priced protocol before understanding suitability and limitations.

Sources: what is established and what needs checking

For general risks and device questions, consult FDA microneedling safety information. For possible benefits, expected reactions and general precautions, consult the American Academy of Dermatology. These resources discuss microneedling; they do not validate the four Réhabital formulations or establish that combining a particular product with needling is appropriate.

Option names and appointment length come from the clinic catalogue. General medical sources do not establish comparative effectiveness, Canadian regulatory status or suitability for your skin. An offered service and a demonstrated benefit for a specific product are different facts. This article makes that distinction visible so you can ask informed questions without turning commercial terminology into a medical promise or a guarantee of superior results.